Injective (INJ) Price

Injective is a Layer-1 blockchain platform designed for building powerful DeFi and Web3 applications. As the native asset of the Injective ecosystem, INJ powers the network and its rapidly growing ecosystem. Key features of INJ include: - Interoperability: Injective is optimized for cross-chain compatibility and seamless integration with other blockchains. - DeFi focus: It provides developers with plug-and-play modules for creating advanced decentralized finance applications. - Fast transactions: Injective offers high throughput and quick finality for efficient DeFi operations. - Robust ecosystem: The Injective ecosystem is expanding rapidly with various DeFi protocols and Web3 projects. As of 2026-05-07, INJ has a market cap of $388.40M and is ranked #136 by market capitalization. The current price of INJ is $3.884, with a 24-hour trading volume of $198.72K. The circulating supply is 100.00M INJ INJ tokens out of a total supply of 100.00M INJ. Injective was launched in September 2020 and has since gained significant traction in the DeFi space. It was incubated by Binance and is backed by prominent investors like Pantera Capital and Jump Crypto.

Injective was created on September 29, 2020. The project launched its native token INJ on this date, marking the official creation of the cryptocurrency. Since then, Injective has grown to become a prominent player in the Web3 and DeFi space, offering a fast and interoperable Layer-1 blockchain for building decentralized finance applications. As of 2026-05-07, Injective has a market cap of $388.40M and is ranked 136 among all cryptocurrencies. The current price of INJ is $3.884, with a 24-hour trading volume of $198.72K.

The founders of Injective are Eric Chen and Albert Chon. They co-founded Injective Labs, the company behind INJ, in 2018. Eric Chen serves as the CEO while Albert Chon is the CTO. Both have backgrounds in computer science and finance, with experience at major tech companies and financial institutions. They aimed to create a decentralized exchange protocol that could offer high performance and interoperability across multiple blockchains. The INJ token was launched in 2020 through a Binance Launchpad initial exchange offering. Since then, Chen and Chon have continued to lead development of the Injective ecosystem, which has grown to become a prominent layer-1 blockchain for decentralized finance applications.

Injective operates as a Layer-1 blockchain optimized for building decentralized finance (DeFi) and Web3 applications. It utilizes a Proof-of-Stake consensus mechanism and offers interoperability with other blockchain networks. The INJ token serves as the native asset of the Injective ecosystem, powering transactions, governance, and staking on the network. Key features of Injective include: 1. Fast transaction processing and low fees 2. Built-in modules for creating DeFi applications 3. Cross-chain compatibility, especially with Cosmos-based chains 4. On-chain order book for decentralized trading INJ tokens can be used for: - Paying transaction fees - Participating in network governance - Staking to secure the network and earn rewards - Providing liquidity in DeFi protocols As of 2026-05-07, Injective has a market cap of $388.40M and is ranked 136 among all cryptocurrencies. The current price of INJ is $3.884, with a 24-hour trading volume of $198.72K. The circulating supply is 100.00M INJ INJ tokens, out of a total supply of 100.00M INJ.

Injective is built on a modular blockchain architecture designed for high performance and interoperability. Key technical components include: 1. Tendermint consensus engine for fast finality 2. Cosmos SDK for modular blockchain development 3. Ethereum Virtual Machine (EVM) compatibility layer 4. Custom modules for DeFi functionality like order matching and derivatives 5. Inter-Blockchain Communication (IBC) protocol for cross-chain interoperability 6. WebAssembly (Wasm) smart contract support This architecture allows Injective to achieve high throughput (up to 10,000 TPS), low latency (sub-second finality), and seamless integration with other blockchains and DeFi protocols. The modular design also enables easy upgrades and customization to support new features and use cases in the future.

The future and roadmap of Injective (INJ) look promising. The project aims to continue enhancing its Layer-1 blockchain infrastructure for DeFi and Web3 applications. Key focus areas include: 1. Scalability improvements to increase transaction throughput and reduce fees 2. Expanding cross-chain interoperability with other major networks 3. Launching new DeFi primitives and financial instruments on the platform 4. Growing the developer ecosystem through grants and hackathons 5. Partnerships with traditional finance institutions to bridge TradFi and DeFi By 2027, Injective is expected to have significantly expanded its ecosystem of dApps and users. Price predictions suggest INJ could reach $4.682 by then. Looking further ahead, analysts forecast potential prices of $5.410 by 2028 and $6.813 by 2031 as adoption grows. The team continues to innovate on core protocol upgrades and new features to maintain Injective's competitive edge in the rapidly evolving blockchain space. With its focus on performance, security, and real-world use cases, Injective is well-positioned for long-term growth and mainstream adoption in the coming years.

Injective is experiencing an upward trend due to increased adoption and development within its ecosystem. The recent launch of new DeFi applications on the Injective platform has attracted more users and investors. Additionally, positive market sentiment and growing interest in layer-1 blockchain solutions have contributed to Injective's price surge to $3.884, up -0.48% in the last 24 hours.

Injective is dropping due to market volatility and profit-taking after its recent price surge. The current price is $3.884, down -0.48% in the last 24 hours. However, Injective's long-term fundamentals remain strong, with growing adoption of its DeFi ecosystem.

Based on Injective's current price of $3.884 and market performance, it could potentially reach $4.682 by 2027, $5.410 by --, and $6.813 by 2031. However, cryptocurrency prices are highly volatile and unpredictable.

Based on current market trends and Injective's performance, INJ is expected to see significant growth in 2027. With its current price of $3.884, analysts project INJ could reach $4.682 by 2027, driven by increased adoption and ecosystem expansion.

The current price of Injective (INJ) is $3.884. As the #136 cryptocurrency by market cap, INJ has seen a -0.48% change in the last 24 hours with a trading volume of $198.72K.

The highest price Injective has ever reached is $52.620. This all-time high was recorded on March 14, 2024.

The lowest price Injective has ever reached is $0.657. This all-time low occurred on November 4, 2020, shortly after the token's initial launch.

Currently, 1 INJ is worth $3.884.

Injective is valuable due to its role in powering the Injective ecosystem, a fast Layer-1 blockchain for DeFi and Web3 applications. As the native asset, INJ is used for governance, staking, and transaction fees, driving demand. With a limited supply of ∞ tokens and growing adoption, INJ's value is expected to increase over time.

As of 2026-05-07, there are 100.00M INJ INJ tokens in circulation, with a total supply of 100.00M INJ INJ. The maximum supply of Injective is capped at ∞ tokens.

No, Injective mining is not profitable. INJ uses a Proof-of-Stake consensus mechanism, which doesn't involve traditional mining. Instead, token holders can stake their INJ to secure the network and earn rewards.

Injective was officially launched on October 19, 2020. This date marks the beginning of INJ's journey in the cryptocurrency market, introducing its innovative blockchain platform for DeFi and Web3 applications.

Currently, one INJ costs $3.884.

You can buy Injective through centralized or decentralized exchanges(Gate.com). Simply create an account, complete identity verification, deposit funds, and place an order to buy INJ at $3.884.

To purchase INJ, create an account on a reputable cryptocurrency exchange(Gate.com), complete identity verification, deposit funds using bank transfer or card, navigate to INJ trading pair, enter purchase amount, and confirm your transaction. Store your INJ in a secure wallet for safekeeping.

Yes, Injective is considered safe and legitimate. It's a well-established cryptocurrency ranking 136 by market cap ($388.40M). Injective operates on a secure blockchain platform and has gained recognition in the Web3 and DeFi space since its launch in 2020.

Injective is the native token of the Injective blockchain, used for governance, staking, and transaction fees. It powers the ecosystem's DeFi applications and provides utility across the Injective network.

Yes, Injective has a promising future. As a leading Layer-1 blockchain for DeFi and Web3 applications, Injective is well-positioned for growth. Its current price of $3.884 and market cap of $388.40M indicate strong potential. By 2031, Injective could reach $6.813, driven by increased adoption and ecosystem expansion.

Yes, Injective has the potential to reach $100. Given its current price of $3.884 and market cap of $388.40M, reaching $100 is feasible in the long term. Injective's strong fundamentals, growing ecosystem, and increasing adoption in DeFi and Web3 applications could drive significant price appreciation in the coming years.

Injective has the potential to reach $52.620 or higher in the future. Its current price is $3.884, with a market cap of $388.40M. Analysts predict it could hit $4.682 by 2027 and $6.813 by 2031, driven by increased adoption and ecosystem growth.